• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Trevi Therapeutics Inc (NQ: TRVI )

    3.310 +0.190 (+6.09%)
    Streaming Delayed Price Updated: 10:22 AM EDT, Oct 21, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 542,104
    Open 3.160
    Bid (Size) 3.280 (12)
    Ask (Size) 3.310 (5)
    Prev. Close 3.120
    Today's Range 3.160 - 3.350
    52wk Range 0.9700 - 4.000
    Shares Outstanding 60,069,512
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Why Trevi Therapeutics Could Be a Triple-Bagger Biotech Stock
    Wall Street analysts see big potential upside for small-cap biopharma firm Trevi Therapeutics. So, what does the firm do and how does it stand out? 
    Via MarketBeat
    Exposures Product Safety
    TRVI Stock Earnings: Trevi Therapeutics Misses EPS for Q2 2024
    TRVI stock results show that Trevi Therapeutics missed analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace

    Performance

    YTD
    +154.62%
    +154.62%
    1 Month
    -3.78%
    -3.78%
    3 Month
    +17.79%
    +17.79%
    6 Month
    +12.59%
    +12.59%
    1 Year
    +87.01%
    +87.01%

    More News

    Read More
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    TRVI Stock Earnings: Trevi Therapeutics Misses EPS for Q1 2024
    Via InvestorPlace
    TRVI Stock Earnings: Trevi Therapeutics Beats EPS for Q4 2023
    Via InvestorPlace
    Trevi Therapeutics: Q4 Earnings Insights
    Via Benzinga
    Earnings Outlook For Trevi Therapeutics
    Via Benzinga
    Trevi Therapeutics's Earnings: A Preview
    Via Benzinga
    Recap: Trevi Therapeutics Q1 Earnings
    Via Benzinga
    Earnings Scheduled For March 20, 2024
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Earnings Outlook For Trevi Therapeutics
    Via Benzinga
    Earnings Scheduled For November 9, 2023
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Earnings Scheduled For August 10, 2023
    Via Benzinga
    Earnings Preview: Trevi Therapeutics
    Via Benzinga
    Earnings Scheduled For May 11, 2023
    Via Benzinga
    Earnings Scheduled For March 16, 2023
    Via Benzinga
    Why Glory Star New Media Group Shares Are Trading Higher By 122%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For March 14, 2023
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For April 12, 2023
    Via Benzinga
    Trevi Therapeutics, Inc. Discusses Progress and 2022 Success of Clinical Studies for Its Investigational Oral Therapy Haduvio(TM) with The Stock Day Podcast
    Via Newsfile
    Why Manchester United Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Earnings Scheduled For November 10, 2022
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.